Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating anti-inflammatory strategy to improve outcomes after aneurysmal subarachnoid hemorrhage.</summary>

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Bonn | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Status: UNKNOWN